Determination of thymus and activation-regulated chemokine (TARC)-contents in scales of atopic dermatitis

Journal of Dermatological Science

Volumn 34, Issue 3, 2004, Pages 237-240

  Morita, Eishin ^a   Hiragun, Takaaki ^b   Mihara, Shoji ^b   Kaneko, Sakae ^a   Matsuo, Hiroaki ^a   Zhang, Yan ^a   Dekio, Satoshi ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Atopic dermatitis; IgE; TARC

Indexed keywords

IMMUNOGLOBULIN E; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ARTICLE; ATOPIC DERMATITIS; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; EOSINOPHIL; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; SKIN DEFECT;

EID: 2142657780     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2004.02.001     Document Type: Letter

References (10)

1. Imai T., Yoshida T., Baba M., Nishimura M., Kakizaki M., Yoshie O. Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J. Biol. Chem. 271:1996;21514-21521
2. Kakinuma T., Nakamura K., Wakugawa M., Mitsui H., Tada Y., Saeki H., et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J. Allergy. Clin. Immunol. 107:2001;535-541
3. Vestergaard C., Bang K., Gesser B., Yoneyama H., Matsushima K., Larsen C.G. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA + CCR4 + lymphocytes into lesional atopic dermatitis skin. J. Invest. Dermatol. 115:2000;640-646
4. Horikawa T., Nakayama T., Hikita I., Yamada H., Fujisawa R., Bito T., et al. IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis. Int. Immunol. 14:2002;767-773
5. Sigurs N., Hattevig G., Kjellman B., Kjellman N.I.M., Nillson L., Bjorksten B. Appearance of atopic disease in relation to serum IgE antibodies in children followed up from birth for 4 to 15 years. J. Allergy Clin. Immunol. 94:1994;757-763
6. Morita E., Kameyoshi Y., Hiragun T., Mihara S., Yamamoto S. The C-C chemokines, RANTES and eotaxin, in atopic dermatitis. Allergy. 56:2001;194-195
7. Zheng X., Nakamura K., Furukawa H., Nishibu A., Takahashi M., Tojo M., et al. Demonstration of TARC and CCR4 mRNA expression and distribution using in situ RT-PCR in the lesional skin of atopic dermatitis. J. Dermatol. 30:2003;26-32
8. Nickel R.G., Casolaro V., Wahn U., Beyer K., Barnes K.C., Plunkett B.S., et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J. Immunol. 164:2000;1612-1616
9. Sekiya T., Tsunemi Y., Miyamasu M., Ohta K., Morita A., Saeki H., et al. Variations in the human Th2-specific chemokine TARC gene. Immunogenetics. 54:2003;742-745
10. Tsuda T., Tohyama M., Yamasaki K., Shirakata Y., Yahata Y., Tokumaru S., et al. Lack of evidence for TARC/CCL17 production by normal human keratinocytes in vitro. J. Dermatol. Sci. 31:2003;37-42